IGF-1 promotes the development and cytotoxic activity of human NK cells

[1]  M. Caligiuri,et al.  miR-155 regulates IFN-γ production in natural killer cells. , 2012, Blood.

[2]  T. Fehniger,et al.  MicroRNA-Deficient NK Cells Exhibit Decreased Survival but Enhanced Function , 2012, The Journal of Immunology.

[3]  A. Dayton,et al.  MicroRNA regulation of STAT4 protein expression: rapid and sensitive modulation of IL-12 signaling in human natural killer cells. , 2011, Blood.

[4]  C. Lutz,et al.  Cutting Edge: MicroRNA-181 Promotes Human NK Cell Development by Regulating Notch Signaling , 2011, The Journal of Immunology.

[5]  L. Lanier,et al.  miR-150 regulates the development of NK and iNKT cells , 2011, The Journal of experimental medicine.

[6]  P. Greenberg,et al.  Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity. , 2011, Blood.

[7]  N. Hara,et al.  Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis. , 2010, Urology.

[8]  C. Croce,et al.  Oncogenic role of miR-483-3p at the IGF2/483 locus. , 2010, Cancer research.

[9]  Tak W. Mak,et al.  Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo , 2009, The Journal of experimental medicine.

[10]  P. Greenberg,et al.  RasGRP1 Is Required for Human NK Cell Function1 , 2009, The Journal of Immunology.

[11]  Mark Coles,et al.  The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development , 2009, Nature Immunology.

[12]  Ryan M. O’Connell,et al.  MicroRNAs: new regulators of immune cell development and function , 2008, Nature Immunology.

[13]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[14]  Todd A Fehniger,et al.  Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. , 2007, Immunity.

[15]  J. Buer,et al.  Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells , 2006, Journal of leukocyte biology.

[16]  L. Lanier,et al.  Natural killer cells as an initial defense against pathogens , 2006, Current Opinion in Immunology.

[17]  J. P. Santo.  NATURAL KILLER CELL DEVELOPMENTAL PATHWAYS: A Question of Balance , 2006 .

[18]  A. Rudensky,et al.  A function for interleukin 2 in Foxp3-expressing regulatory T cells , 2005, Nature Immunology.

[19]  D. F. Barber,et al.  Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells , 2005, The Journal of experimental medicine.

[20]  P. Ramchandani,et al.  A question of balance , 2004, Nature.

[21]  S. Hankinson,et al.  Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.

[22]  O. Nakamura,et al.  IGF-I Overexpression causes fetal loss during placentation in mice. , 2004, The Journal of reproduction and development.

[23]  Dolca Thomas,et al.  The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic1 , 2004, The Journal of Immunology.

[24]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[25]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[26]  P. Park,et al.  Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential , 2003, The Journal of experimental medicine.

[27]  T. Ley,et al.  The orphan granzymes of humans and mice. , 2003, Current opinion in immunology.

[28]  M. Caligiuri,et al.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. , 2003, Blood.

[29]  Kazuyoshi Takeda,et al.  New aspects of natural-killer-cell surveillance and therapy of cancer , 2002, Nature Reviews Cancer.

[30]  M. Caligiuri,et al.  Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset , 2001 .

[31]  R. Baserga.  The contradictions of the insulin-like growth factor 1 receptor , 2000, Oncogene.

[32]  S. Soddu,et al.  Growth and Differentiation Signals by the Insulin-like Growth Factor 1 Receptor in Hemopoietic Cells Are Mediated through Different Pathways* , 1999, The Journal of Biological Chemistry.

[33]  W. Buurman,et al.  Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation. , 1999, Cytokine & growth factor reviews.

[34]  S. Anderson,et al.  Role of a STAT binding site in the regulation of the human perforin promoter. , 1999, Journal of immunology.

[35]  Ahmed Mansouri,et al.  Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2 , 1999, Nature.

[36]  Ø. Bruserud,et al.  Insulin‐Like Growth Factor‐1 (IGF‐1) has a Costimulatory Effect on Proliferation of Committed Progenitors Derived from Human Umbilical Cord CD34+ Cells , 1998, Stem cells.

[37]  M. White,et al.  The IRS-signalling system: A network of docking proteins that mediate insulin action , 1998, Molecular and Cellular Biochemistry.

[38]  M. Bidlingmaier,et al.  Effects of growth hormone and insulin‐like growth factor I binding to natural killer cells , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[39]  R. Badolato,et al.  Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry. , 1994, The Journal of clinical endocrinology and metabolism.

[40]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[41]  C. Heijnen,et al.  Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. , 1992, Endocrinology.

[42]  Aron Dc.  Insulin-like growth factor I and erythropoiesis. , 1992 .

[43]  R. Furlanetto,et al.  Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. , 1991, The Journal of clinical endocrinology and metabolism.

[44]  Z. Hochberg,et al.  Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. , 1988, The Journal of clinical investigation.

[45]  R. Herberman,et al.  Lymphocyte-mediated cytotoxicity. , 1987, Pediatric annals.

[46]  L. Lanier,et al.  The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. , 1986, Journal of immunology.

[47]  Carmen Domingo.  Biology , 1929, Nature.

[48]  Eric O Long,et al.  Functional analysis of human NK cells by flow cytometry. , 2010, Methods in molecular biology.

[49]  R. Dantzer,et al.  Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. , 2008, Cellular immunology.

[50]  J. D. Di Santo.  Natural killer cell developmental pathways: a question of balance. , 2006, Annual review of immunology.

[51]  M. Caligiuri,et al.  Human natural killer cells : a unique innate immunoregulatory role for the CD 56 bright subset , 2001 .

[52]  T. Ghayur,et al.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. , 2001, Blood.

[53]  L. Zon,et al.  Hematopoiesis: An Evolving Paradigm for Stem Cell Biology , 2008, Cell.